NFE2L2 and neoplasm: Tumors produced by NIH3T3_vGPCR–shNrf2_2.1 tend to be smaller than the ones observed in the NIH3T3_vGPCR group (Figures 7B–C); probably due to the significant delay in tumor onset found for Nrf2 silenced cells (Figure 7D).